收藏切换
Research progress in the preclinical disease model for primary brain cancer
收藏切换
PDF
Zhi-yuan LIANG1, 2, Zhi-ying HUANG2, Xing-chao GENG1, Zhi LIN1, Zhe QU1
Chinese Journal of New Drugs | 2023, 32(8) : 787 - 792
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(8): 787-792
Research progress in the preclinical disease model for primary brain cancer
Full
Zhi-yuan LIANG1, 2, Zhi-ying HUANG2, Xing-chao GENG1, Zhi LIN1, Zhe QU1
Affiliations
  • 1Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China
  • 2School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
Published: 2023-04-30
Outline
收藏切换

Primary brain cancer is a heterogeneous group of tumors arising from cells within the central nervous system. The cure rate and survival period of patients with common malignant primary brain cancers are low, and their treatment methods and therapeutic effects are also quite limited. Therefore, it is necessary to construct appropriate tumor models to study the molecular biology of the disease, preclinical pharmacodynamic and safety evaluation of new anti-tumor drugs and/or the therapeutic methods. This review summarizes the research progress of in vitro and in vivo models of primary brain cancer. In vitro models mainly include the culture of brain cancer cell line, organoids and the brain slices. In vivo models mainly include the rodent models and other model organisms such as the fruit fly and zebrafish. At present, lots of primary brain cancer disease models with their own advantages and disadvantages have been developed, but these models cannot fully simulate the complexities of brain tumors in humans. Therefore, researchers are developing more complex disease models based on the existing models to study the primary brain tumor treatment methods, screen and evaluate therapeutic drugs.

primary brain cancer  /  in vitro models  /  in vivo models  /  organoids  /  model animal
Zhi-yuan LIANG, Zhi-ying HUANG, Xing-chao GENG, Zhi LIN, Zhe QU. Research progress in the preclinical disease model for primary brain cancer[J]. Chinese Journal of New Drugs, 2023 , 32 (8) : 787 -792 .
Year 2023 volume 32 Issue 8
PDF
23
7
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-06
  • Published:2023-04-30
Article Data
Affiliations
History
  • Accepted:2022-10-26
Funding
Affiliations
    1Beijing Key Laboratory for Safety Evaluation of Drugs, National Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing 100176, China
    2School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT